Despite heterogeneity playing a very considerable role in the GRADEing of individual outcomes, the GDG suggests that there may be individual strains with favorable effects for children with AP‐DGBIs, a statement informed by a GRADEd conclusion for pain intensity and a favorable trend for treatment success.
← all excerpts
ESPGHAN/NASPGHAN guidelines for treatment of irritable bowel syndrome and functional abdominal pain-not otherwise specified in children aged 4-18 years.
1
—
—